Medapro ®-CF amnion membrane-derived allografts are human biologic tissues derived from the amniotic membrane of the placenta.
- Regulated under the PHS ACT as an HCT/P, section 361; 21 CFR 1271
Human cells, tissues, or cellular or tissue-based products (HCT/Ps) containing or consisting of human cells or tissues that are intended for implantation, transplantation, infusion, or transfer into a human recipient.
- Recovered through patient donation programs via C-Section
- Immediately processed within the first hour of donation to ensure quality and viability
- Minimally manipulated and FDA cleared for homologous use